-
2 Yazı
-
1 Fotoğraflar
-
0 Videolar
-
SEO saat DengyueMed
-
Hayatımızda HongKong
-
Kimden hongkong
-
Ardından: 0 people
Son Güncellemeler
-
Luvometinib: A New Exploration in Targeted Therapy, from MET-Abnormal Lung Cancer to Multi-Cancer LayoutIn the field of oncology targeted therapy, the development of precision drugs for specific gene abnormalities has always been a key direction for breaking through challenges and extending patient survival. DengyuePharma has discovered that Luvometinib (trade name: Fumaining®), an independently developed Class 1 innovative drug by Fosun Pharma, stands out in the treatment of MET gene...0 Yorumlar 0 hisse senetleri 8 Views 0 önizlemePlease log in to like, share and comment!
-
0 Yorumlar 0 hisse senetleri 1 Views 0 önizleme
Daha Hikayeler